ValiRx PLC Sustainability Reports
ValiRx PLC is a biopharmaceutical company focused on the development of early-stage cancer therapeutics and women's health treatments. The company identifies promising scientific innovations and advances them through preclinical development towards commercial translation.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800VQKB9SJCQDET40
FIGI: BBG001S7SN00
12 reports from 2014 to 2025